Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat

Pediatric Research

Volumn 62, Issue 3, 2007, Pages 291-294

  Coimbra, Roney S ^a   Loquet, Gérard ^b   Leib, Stephen L ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; SODIUM CHLORIDE;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL MENINGITIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFICACY; EVOKED BRAIN STEM AUDITORY RESPONSE; HEARING LOSS; HISTOLOGY; NERVE CELL; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; SOUND PRESSURE;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS; CHILD; COCHLEA; DEXAMETHASONE; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HEARING LOSS, SENSORINEURAL; HUMANS; MENINGITIS, PNEUMOCOCCAL; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 34548128816     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/PDR.0b013e318123fb7c     Document Type: Article

References (37)

1. Yogev R, Guzman-Cottrill J 2005 Bacterial meningitis in children: critical review of current concepts. Drugs 65:1097-1112
2. Hoogman M, van de Beek D, Weisfelt M, de Gans J, Schmand B 2007 Cognitive outcome in adults after bacterial meningitis. J Neurol Neurosurg Psychiatry [Epub ahead of print]
3. Merkelbach S, Sittinger H, Schweizer I, Muller M 2000 Cognitive outcome after bacterial meningitis. Acta Neurol Scand 102:118-123
4. Dodge PR, Davis H, Feigin RD, Holmes SJ, Kaplan SL, Jubelirer DP, Stechenberg BW, Hirsh SK 1984 Prospective evaluation of hearing impairment as a sequela of acute bacterial meningitis. N Engl J Med 311:869-874
5. Oostenbrink R, Maas M, Moons KG, Moll HA 2002 Sequelae after bacterial meningitis in childhood. Scand J Infect Dis 34:379-382
6. Fortnum HM 1992 Hearing impairment after bacterial meningitis: a review. Arch Dis Child 67:1128-1133
7. Dichgans M, Jager L, Mayer T, Schorn K, Pfister HW 1999 Bacterial meningitis in adults: demonstration of inner ear involvement using high-resolution MRI. Neurology 52:1003-1009
8. Bhatt SM, Lauretano A, Cabellos C, Halpin C, Levine RA, Xu WZ, Nadol JB Jr, Tuomanen E 1993 Progression of hearing loss in experimental pneumococcal meningitis: correlation with cerebrospinal fluid cytochemistry. J Infect Dis 167:675-683
9. Bhatt S, Halpin C, Hsu W, Thedinger BA, Levine RA, Tuomanen E, Nadol JB Jr 1991 Hearing loss and pneumococcal meningitis: an animal model. Laryngoscope 101:1285-1292
10. Klein M, Koedel U, Pfister HW, Kastenbauer S 2003 Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis. Brain Pathol 13:123-132
11. Meli DN, Coimbra RS, Erhart DG, Loquet G, Bellac CL, Täuber MG, Neumann U, Leib SL 2006 Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect Immun 74:3890-3896
12. Girgis NI, Farid Z, Mikhail IA, Farrag I, Sultan Y, Kilpatrick ME 1989 Dexamethasone treatment for bacterial meningitis in children and adults. Pediatr Infect Dis J 8:848-851
13. Lebel MH, Freij BJ, Syrogiannopoulos GA, Chrane DF, Hoyt MJ, Stewart SM, Kennard BD, Olsen KD, McCracken GH Jr 1988 Dexamethasone therapy for bacterial meningitis. Results of two double-blind, placebo-controlled trials. N Engl J Med 319:964-971
14. Odio CM, Faingezicht I, Paris M, Nassar M, Baltodano A, Rogers J, Saez-Llorens X, Olsen KD, McCracken GH Jr 1991 The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med 324:1525-1531
15. Grandgirard D, Leib SL 2006 Strategies to prevent neuronal damage in paediatric bacterial meningitis. Curr Opin Pediatr 18:112-118
16. Arditi M, Mason EO Jr, Bradley JS, Tan TQ, Barson WJ, Schutze GE, Wald ER, Givner LB, Kim KS, Yogev R, Kaplan SL 1998 Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use. Pediatrics 102:1087-1097
17. Kanra GY, Ozen H, Secmeer G, Ceyhan M, Ecevit Z, Belgin E 1995 Beneficial effects of dexamethasone in children with pneumococcal meningitis. Pediatr Infect Dis J 14:490-494
18. Kennedy WA, Hoyt MJ, McCracken GH Jr 1991 The role of corticosteroid therapy in children with pneumococcal meningitis. Am J Dis Child 145:1374-1378
19. McIntyre PB, Berkey CS, King SM, Schaad UB, Kilpi T, Kanra GY, Perez CM 1997 Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA 278:925-931
20. Prober CG 1995 The role of steroids in the management of children with bacterial meningitis. Pediatrics 95:29-31
21. Schaad UB, Kaplan SL, McCracken GH Jr 1995 Steroid therapy for bacterial meningitis. Clin Infect Dis 20:685-690
22. Irazuzta J, Pretzlaff RK, DeCourten-Myers G, Zemlan F, Zingarelli B 2005 Dexamethasone decreases neurological sequelae and caspase activity. Intensive Care Med 31:146-150
23. Zysk G, Bruck W, Gerber J, Bruck Y, Prange HW, Nau R 1996 Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 55:722-728
24. Leib SL, Heimgartner C, Bifrare YD, Loeffler JM, Täuber MG 2003 Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr Res 54:353-357
25. Addison J, Kim HH, Richter CP 2006 Cochlear preservation after meningitis: an animal model confirmation of adjunctive steroid therapy. Laryngoscope 116:279-282
26. Rappaport JM, Bhatt SM, Burkard RF, Merchant SN, Nadol JB Jr 1999 Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac. J Infect Dis 179:264-268
27. Leib SL, Clements JM, Lindberg RL, Heimgartner C, Loeffler JM, Pfister LA, Täuber MG, Leppert D 2001 Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 124:1734-1742
28. Spreer A, Gerber J, Hanssen M, Schindler S, Hermann C, Lange P, Eiffert H, Nau R 2006 Dexamethasone increases hippocampal neuronal apoptosis in a rabbit model of Escherichia coli meningitis. Pediatr Res 60:210-215
29. Chang-Ling T, Neill AL, Hunt NH 1992 Early microvascular changes in murine cerebral malaria detected in retinal wholemounts. Am J Pathol 140:1121-1130
30. Kastenbauer S, Klein M, Koedel U, Pfister HW 2001 Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat. Brain Res 904:208-217
31. Shinohara T, Bredberg G, Ulfendahl M, Pyykko I, Olivius NP, Kaksonen R, Lindstrom B, Altschuler R, Miller JM 2002 Neurotrophic factor intervention restores auditory function in deafened animals. Proc Natl Acad Sci U S A 99:1657-1660
32. Osborne MP, Comis SD, Tarlow MJ, Stephen J 1995 The cochlear lesion in experimental bacterial meningitis of the rabbit. Int J Exp Pathol 76:317-330
33. Juhn SK 1988 Barrier systems in the inner ear. Acta Otolaryngol Suppl 458:79-83
34. Geal-Dor M, Freeman S, Li G, Sohmer H 1993 Development of hearing in neonatal rats: air and bone conducted ABR thresholds. Hear Res 69:236-242
35. Nishida Y, Rivolta MN, Holley MC 1998 Timed markers for the differentiation of the cuticular plate and stereocilia in hair cells from the mouse inner ear. J Comp Neurol 395:18-28
36. Weisfelt M, Hoogman M, van de Beek D, de Gans J, Dreschler WA, Schmand BA 2006 Dexamethasone and long-term outcome in adults with bacterial meningitis. Ann Neurol 60:456-468
37. de Gans J, van de Beek D 2002 Dexamethasone in adults with bacterial meningitis. N Engl J Med 347:1549-1556